INVERSAGO PHARMA
A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the treatment of Prader-Willi Syndrome (PWS), Type-1 Diabetes (T1D), obesity and other metabolic disorders such as non-alcoholic steatohepatitis (NASH). Inversago’s technology addresses limits associated with first generation CB1 blockers, allowing the company to exploit their full medical potential.
INVERSAGO PHARMA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Website Url:
http://www.inversago.com
Total Employee:
1+
Status:
Active
Total Funding:
42 M USD
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Continuous Precision Medicine
Continuous Precision Medicine™ is a leader in the fight against the opioid epidemic.
Giiant Pharma
Giiant Pharma is a preclinical-stage biotech company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
Metera Pharmaceuticals
Metera Pharmaceuticals is a preclinical stage biotechnology company.
Neuraly
Neuraly is a startup biotech company.
Portal Instruments
Portal Instruments is an early stage company that offers medical device.
Scarless Laboratories
Scarless Laboratories is a Beverly Hills-based research-focused early-stage biotechnology company.
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Current Advisors List
Board_member
2020-09-01
Board_member
2020-08-01
Board_member
2020-09-01
Current Employees Featured
Glenn S. Vraniak Chief Financial Officer @ Inversago Pharma
Chief Financial Officer
2022-05-01
Jamie Stiff Director @ Inversago Pharma
Director
2018-07-01
François Ravenelle President and CEO @ Inversago Pharma
President and CEO
2016-12-01
Founder
Investors List
AQC Capital
AQC Capital investment in Series B - Inversago Pharma
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Series B - Inversago Pharma
Amorchem
Amorchem investment in Series B - Inversago Pharma
JDRF T1D Fund
JDRF T1D Fund investment in Series B - Inversago Pharma
adMare Bio Innovations
adMare Bio Innovations investment in Series B - Inversago Pharma
Genesys Capital
Genesys Capital investment in Series B - Inversago Pharma
Forbion Capital Partners
Forbion Capital Partners investment in Series B - Inversago Pharma
AQC Capital
AQC Capital investment in Series A - Inversago Pharma
JDRF T1D Fund
JDRF T1D Fund investment in Series A - Inversago Pharma
Anges Quebec
Anges Quebec investment in Series A - Inversago Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-17 | Inversago Pharma Appoints Glenn S. Vraniak as Chief Financial Officer |
Official Site Inspections
http://www.inversago.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Inversago Pharma"
Our Company – Inversago Pharma
Sep 8, 2023 Before joining Inversago in August 2022, Jean-Daniel started his career in private practice with a focus in business and securities law matters before joining Neptune Wellness Solutions Inc., and subsidiary Acasti Pharma …See details»
Inversago Pharma - Crunchbase Company Profile
Organization. Inversago Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Inversago …See details»
Novo Nordisk to acquire Inversago Pharma to develop …
Aug 10, 2023 Bagsværd, Denmark and Montreal, Canada, 10 August 2023 – Novo Nordisk A/S and Inversago Pharma today announced that Novo Nordisk has agreed to acquire Inversago for up to 1.075 billion US dollars in cash if …See details»
Forbion Portfolio Company Inversago Pharma to be acquired by …
Aug 10, 2023 Naarden, The Netherlands, 10 August 2023 – Forbion, a leading European life sciences venture capital firm, today announces that Novo Nordisk has agreed to acquire its …See details»
Inversago Pharma - Funding, Financials, Valuation & Investors
Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists. New. Resources. Advanced Search. ... How much funding has this …See details»
Inversago Pharma Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Inversago Pharma Inc of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Inversago Pharma Company Profile - Office Locations ... - Craft
Inversago Pharma is a specialized, preclinical-stage biotech company. The Company develops cannabinoid-1 receptor blockers and antagonists for the treatment of prader-willi syndrome, …See details»
News at Inversago Pharma - The Official Board
Novo Nordisk has 16 subsidiaries including Cardior Pharmaceuticals, Dicerna Pharmaceuticals and Inversago Pharma. They are in: Pharmaceuticals 76%; Biotechnology 12%; Other 12%. …See details»
Novo Nordisk to acquire Inversago Pharma to develop new
Aug 10, 2023 BAGSVÆRD, Denmark and MONTREAL, Aug. 10, 2023 /CNW/ - Novo Nordisk A/S and Inversago Pharma today announced that Novo Nordisk has agreed to acquire …See details»
Investors – Inversago Pharma
Sep 8, 2023 Inversago is a clinical stage biopharmaceutical company dedicated to developing therapies for patients suffering from debilitating metabolic diseases. A privately-owned …See details»
Inversago - VentureRadar
"A specialized, preclinical-stage biotech company, Inversago Pharma develops new generations of peripherally-restricted cannabinoid-1 receptor (CB1) inverse agonists/ antagonists for the …See details»
Inversago Pharma - Products, Competitors, Financials, Employees ...
Inversago Pharma was founded in 2015. Where is Inversago Pharma's headquarters? Inversago Pharma's headquarters is located at 1100 Rene-Levesque Boulevard West, Montreal. What is …See details»
Inversago Pharma 2025 Company Profile: Valuation, Investors ...
Inversago Pharma General Information Description. Developer of medical drugs designed to treat patients suffering from metabolic and fibrotic disorders. The company's drugs are developed …See details»
Anges Québec - Managing a virtual team : The 3 golden rules of …
François Ravenelle, CEO and Founder of Inversago Pharma, a Montreal biotech firm that is tackling the treatment of Prader-Willi syndrome (PWS), has just closed a $7M Series A round …See details»
Inversago Pharma - Contacts, Employees, Board Members
Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists ... Experience the new Crunchbase, powered by AI . Experience the new …See details»
Inversago Pharma - Overview, News & Similar companies
MONTREAL--(BUSINESS WIRE)--Inversago Pharma Inc. (“Inversago”), a leader in the development of peripherally-acting CB1 receptor (CB1r) blockers to address complications …See details»
Novo Nordisk buys Inversago for $1bn as Wegovy sales soar
Aug 10, 2023 The investment in Inversago comes as Novo Nordisk reported obesity sales that grew 157% in the first half of the year to more than DKK 18 billion ($2.7 billion), despite …See details»
Novo Nordisk to acquire Inversago Pharma to develop new …
Aug 10, 2023 Bagsværd, Denmark and Montreal, Canada, 10 August 2023 – Novo Nordisk A/S and Inversago Pharma today announced that Novo Nordisk has agreed to acquire Inversago …See details»
Sapiens Acquires AdvantageGo to Expand Global P&C Platform …
3 days ago "Joining Sapiens means becoming part of a leading global product organization that will amplify our capabilities and enhance our solutions, creating greater opportunities for our …See details»
Inversago Pharma Raises $95 million CAD in Series C Financing
Oct 17, 2022 – Series C financing led by NEA – Provides advancement of INV-202 Phase 2 clinical trial in Diabetic Kidney Disease in Q4 . MONTREAL (CANADA) – October 17, 2022 – …See details»